Pharmaceutical mergers and megamergers stifle innovation
RUBY WALLAU FOR STAT
Pharmaceutical mergers and megamergers, like the AbbVie and Allergan deal, may be good for business, bit it isn't good for innovation — or consumers.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario